Latest News & Features
Americas
Generative AI is transforming the biotech industry, so it’s crucial to have an IP strategy—in particular, for trade secret and/or patent protection. Dean Pelletier of Pelletier Law explains. 24 April 2025
Europe
Gene editing company ToolGen “seeks fair licensing agreement” for alleged infringement by rival | High-value sickle cell treatment CASGEVY was “born from ToolGen’s proprietary CRISPR RNP tech” says complaint | Potter Clarkson instructed. 22 April 2025
Careers
The firm hired Brent Babcock as a partner in New York, bringing experience in cases involving biotechnology and medical devices. 22 April 2025
Americas
With a career spanning an iconic consumer brand and big pharma, INTA's current president is focused on amplifying the voice of in-house counsel, finds Muireann Bolger. 22 April 2025
Careers
Firm’s chair says Fenwick has been active in market for a long time and “waiting to find the right opportunity to deepen our bench and presence”. 17 April 2025
Americas
The bipartisan legislative push could create big hurdles for drug development, with concerns mounting over limited patent protections and increased litigation risks, hears Marisa Woutersen. 17 April 2025
Big Pharma
Massachusetts lawsuit claims subsidiary of UK pharma company unlawfully re-patented eculizumab, resulting in overpayments of more than $2 billion. 17 April 2025
Americas
Prompter patent issue will provide earlier protection for inventions and could avoid need for Quick Path Information Disclosure Statements, says USPTO. 17 April 2025
Careers
New partner brings 16 years of experience in biotechnology and pharmaceutical patent prosecution to Chicago | Regularly advises on animal biotechnology, antibodies and biologics, cell biology, chemical technologies, medical devices, and vaccines. 16 April 2025
Big Pharma
Court hears arguments from J&J and Teva to determine whether a patent blocking generic versions of Invega Sustenna will be upheld | J&J fights to protect its last remaining Orange Book patent covering Invega Sustenna. 15 April 2025